HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- Success of T-cell therapy in hematologic malignancies cause for optimism, concern
-
- Discussion about treatment of early-stage Hodgkin’s lymphoma needed radiation oncologist Leonard R. Prosnitz, MD; Christopher Kelsey, MD
- ASH presents service award
- Bevacizumab/erlotinib combined therapy associated with substantial risk of esophageal toxicity
- Institute hires clinical director
- North Shore-LIJ creates VP post
- Physician joins CCP committee
- The top clinically relevant publications in thrombosis and anticoagulation Stephan Moll, MD
- Lymphoseek approved to locate lymph nodes in breast cancer, melanoma
-
- Career in transplantation offers unique rewards, challenges William Wood, MD
- Inferior OS found in certain patients with pre-existing CLL
- AGS-003 plus sunitinib extended survival in metastatic RCC
- COPD failed to provide independent risk factor for lung cancer
- Novel target for pancreatic cancer therapy identified
- S. pneumoniae prominent among bloodstream infections in sickle cell disease
- Breast-conserving therapy plus radiation improved survival in patients with early-stage disease
- Maintenance IL-2, GM-CSF may improve response in metastatic melanoma
-
- Tumor-infiltrating lymphocytes fail to predict aggressive tumor biology
- ‘Ugly DUC-ling’ criteria may increase early detection of melanoma